European patients begin receiving world’s first lung cancer vaccine in 'revolutionary' new trial.
👉 A lung cancer patient in the UK has become one of the first to participate in a groundbreaking trial for the world's first vaccine against the disease. Lung cancer is the leading cause of... 顯示更多 翻譯
𝙄𝙨 𝙂𝙪𝙗𝙧𝙖 𝙩𝙝𝙚 𝙣𝙚𝙭𝙩 𝙬𝙚𝙞𝙜𝙝𝙩 𝙡𝙤𝙨𝙨 𝙬𝙞𝙣𝙣𝙚𝙧?
📈 Danish biotech company $GUBRA.CO (Gubra A/S) has skyrocketed in 2024 and is suddenly on the radar of many retail investors. Since its listing on Nasdaq Copenhagen at a price of DKK 110 in March 2023, the share price has risen by... 顯示更多 翻譯
𝙄𝙨 𝙕𝙚𝙖𝙡𝙖𝙣𝙙 𝙋𝙝𝙖𝙧𝙢𝙖 𝙩𝙝𝙚 𝙣𝙚𝙭𝙩 𝙉𝙤𝙫𝙤 𝙉𝙤𝙧𝙙𝙞𝙨𝙠?
🔬 Danish biotech company $ZEAL.CO (Zealand Pharma A/S) has recently presented its results for the first quarter of 2024. As an 'R&D shop' focused on developing new drugs, Zealand Pharma differs from most other companies... 顯示更多 翻譯
🚨🅔🅧-🅓🅘🅥🅘🅓🅔🅝🅓 🅓🅐🅣🅔 🅐🅛🅔🅡🅣🚨
$GSK (GlaxoSmithKline plc ADR) Must own TODAY for Dividend Payment in October
📅 Ex-Dividend Date: August 16th!!!
📅 Payment Date: October 10th
💲 $0.39 per Share, 3.68% Forward Yield
⏰ Frequency: Quarterly (Jan, Apr, Jul, Oct)
Great time to start copying... 顯示更多 翻譯
🔭🅦🅔🅔🅚🅛🅨 🅞🅤🅣🅛🅞🅞🅚🔭
💰𝐏𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨 𝐃𝐢𝐯𝐢𝐝𝐞𝐧𝐝 𝐏𝐚𝐲𝐦𝐞𝐧𝐭𝐬 𝐧𝐞𝐱𝐭 𝐰𝐞𝐞𝐤:
𝐖𝐞𝐝𝐧𝐞𝐬𝐝𝐚𝐲: EPD $0.525 per Share, NEP $0.905 per Share, PAGP $0.3175 per Share
𝐓𝐡𝐮𝐫𝐬𝐝𝐚𝐲: EPR $0.285 per Share, KMI $0.2875 per Share, MAIN $0.245 per Share, O $0.263 per Share, OHI... 顯示更多 翻譯
If you want to gain about 10.000 month with dividends how much will you invest in copytrade you? (I know you can't see the future, just an extimation from previous results)... 顯示更多 翻譯
𝙉𝙤𝙫𝙤 𝙉𝙤𝙧𝙙𝙞𝙨𝙠 𝙘𝙤𝙣𝙩𝙞𝙣𝙪𝙚𝙨 𝙞𝙩𝙨 𝙨𝙩𝙧𝙤𝙣𝙜 𝙥𝙚𝙧𝙛𝙤𝙧𝙢𝙖𝙣𝙘𝙚 𝙞𝙣𝙩𝙤 𝙩𝙝𝙚 𝙛𝙞𝙧𝙨𝙩 𝙝𝙖𝙡𝙛 𝙤𝙛 𝙩𝙝𝙚 𝙮𝙚𝙖𝙧
💊 The Danish diabetes and obesity giant $NOVO-B.CO (Novo Nordisk B A/S) continues its strong performance in the first half of the year, delivering a sales... 顯示更多 翻譯
The earning were not great this time sadly, but novo start going down weeks before as it is not a great stock as I thought. when other farnmaceutical were testing similar drugs novo was loosing straight away... 顯示更多 翻譯
𝙍𝙚𝙖𝙙𝙮 𝙛𝙤𝙧 𝙉𝙤𝙫𝙤 𝙉𝙤𝙧𝙙𝙞𝙨𝙠'𝙨 𝙌𝟮-𝙧𝙚𝙨𝙪𝙡𝙩𝙨?
🫄 Tomorrow morning before market opening, we will get Q2-results from the Danish obesity (and diabetes) treatment giant $NOVO-B.CO (Novo Nordisk B A/S) .
💊 For Novo Nordisk , the second quarter results will be an important test... 顯示更多 翻譯
AZN.L AstraZeneca 0.48% 
GSK.L GlaxoSmithKline 0.43% 
NVS Novartis ADR 0.14% 
AZN AstraZeneca PLC ADR 0.06% 
SNY Sanofi-ADR -0.88%